pneumococcal pneumonia and invasive pneumococcal disease
Vaccines · 2015–2015
2decisions
1medicine
0carried consumer input
0individual submissions
No submission for this condition has carried consumer input, including the 2 made since the comments facility came into use.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| pneumococcal conjugate vaccine, 13-valent Prevention of pneumococcal pneumonia and invasive pneumococcal disease (IPD) in adults aged 65 years and over (non-Indigenous) or 50 years and over… | Jul 2015 | Recommended | none received |
| pneumococcal conjugate vaccine, 13-valent Prevention of pneumococcal pneumonia and invasive pneumococcal disease in adults. The primary program targets non-Indigenous adults at age 65 years and… | Mar 2015 | Not recommended | none received |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 2 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.